» Articles » PMID: 25902512

Head-to-head Antisense Transcription and R-loop Formation Promotes Transcriptional Activation

Overview
Specialty Science
Date 2015 Apr 23
PMID 25902512
Citations 129
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanisms used by antisense transcripts to regulate their corresponding sense mRNAs are not fully understood. Herein, we have addressed this issue for the vimentin (VIM) gene, a member of the intermediate filament family involved in cell and tissue integrity that is deregulated in different types of cancer. VIM mRNA levels are positively correlated with the expression of a previously uncharacterized head-to-head antisense transcript, both transcripts being silenced in colon primary tumors concomitant with promoter hypermethylation. Furthermore, antisense transcription promotes formation of an R-loop structure that can be disfavored in vitro and in vivo by ribonuclease H1 overexpression, resulting in VIM down-regulation. Antisense knockdown and R-loop destabilization both result in chromatin compaction around the VIM promoter and a reduction in the binding of transcriptional activators of the NF-κB pathway. These results are the first examples to our knowledge of R-loop-mediated enhancement of gene expression involving head-to-head antisense transcription at a cancer-related locus.

Citing Articles

Mechanisms underlining R-loop biology and implications for human disease.

Liu J, Li F, Cao Y, Lv Y, Lei K, Tu Z Front Cell Dev Biol. 2025; 13:1537731.

PMID: 40061014 PMC: 11885306. DOI: 10.3389/fcell.2025.1537731.


Mechanism of expression regulation of head-to-head overlapping protein-coding genes INO80E and HIRIP3.

Ryczek N, Lys A, Wanowska E, Kozlowska-Maslon J, Makalowska I Commun Biol. 2025; 8(1):391.

PMID: 40057624 PMC: 11890862. DOI: 10.1038/s42003-025-07815-4.


Non-Coding RNAs in Cancer: Structure, Function, and Clinical Application.

Marton E, Varga A, Domoszlai D, Buglyo G, Balazs A, Penyige A Cancers (Basel). 2025; 17(4).

PMID: 40002172 PMC: 11853212. DOI: 10.3390/cancers17040579.


Gene regulation by convergent promoters.

Wiechens E, Vigliotti F, Siniuk K, Schwarz R, Schwab K, Riege K Nat Genet. 2025; 57(1):206-217.

PMID: 39779959 PMC: 11735407. DOI: 10.1038/s41588-024-02025-w.


The hidden architects of the genome: a comprehensive review of R-loops.

Yadav C, Yadav R, Nanda S, Ranga S, Ahuja P Mol Biol Rep. 2024; 51(1):1095.

PMID: 39460836 DOI: 10.1007/s11033-024-10025-6.


References
1.
Benazzouz A, Duprey P . The vimentin promoter as a tool to analyze the early events of retinoic acid-induced differentiation of cultured embryonal carcinoma cells. Differentiation. 2000; 65(3):171-80. DOI: 10.1046/j.1432-0436.1999.6530171.x. View

2.
Lai F, Orom U, Cesaroni M, Beringer M, Taatjes D, Blobel G . Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature. 2013; 494(7438):497-501. PMC: 4109059. DOI: 10.1038/nature11884. View

3.
Kang Y, Massague J . Epithelial-mesenchymal transitions: twist in development and metastasis. Cell. 2004; 118(3):277-9. DOI: 10.1016/j.cell.2004.07.011. View

4.
Rittling S, Coutinho L, Amram T, Kolbe M . AP-1/jun binding sites mediate serum inducibility of the human vimentin promoter. Nucleic Acids Res. 1989; 17(4):1619-33. PMC: 336896. DOI: 10.1093/nar/17.4.1619. View

5.
Lilienbaum A, Duc Dodon M, Alexandre C, GAZZOLO L, Paulin D . Effect of human T-cell leukemia virus type I tax protein on activation of the human vimentin gene. J Virol. 1990; 64(1):256-63. PMC: 249098. DOI: 10.1128/JVI.64.1.256-263.1990. View